Abstract

Get full access to this article
View all access options for this article.
References
1.
Haider
HKh
Tan
AC
Aziz
S
Chachques
JC
Sim
EK
. Myoblast transplantation for cardiac repair: a clinical perspective . Mol Ther
2004 ; 9 : 14 –23 .
2.
Scorsin
M
Hagege
A
Vilquin
JT
Fiszman
M
Marotte
F
Samuel
JL
. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function . J Thorac Cardiovasc Surg
2000 ; 119 : 1169 –75 .
3.
Huwer
H
Winning
J
Vollmar
B
Welter
C
Lohbach
C
Menger
MD
. Long-term cell survival and hemodynamic improvements after neonatal cardiomyocyte and satellite cell transplantation into healed myocardial cryoinfarcted lesions in rats . Cell Transplant
2003 ; 12 : 757 –67 .
4.
Agbulut
O
Vandervelde
S
Al Attar
N
Larghero
J
Ghostine
S
Leobon
B
. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium . J Am Coll Cardiol
2004 ; 44 : 458 –63 .
5.
Menasche
P
Hagege
AA
Vilquin
JT
Desnos
M
Abergel
E
Pouzet
B
. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction . J Am Coll Cardiol
2003 ; 41 : 1078 –83 .
6.
Kalka
C
Tehrani
H
Laudenberg
B
Vale
PR
Isner
JM
Asahara
T
. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease . Ann Thorac Surg
2000 ; 70 : 829 –34 .
7.
Ye
L
Haider
KhH
Jiang
SJ
Ling
LH
Ge
RW
Law
PK
. Reversal of myocardial injury using genetically modulated human skeletal myoblasts in a rodent cryoinjured heart model . Eur J Heart Fail
2005 ; 7 : 945 –52 .
8.
Haider
HKh
Ye
L
Jiang
S
Ge
R
Law
PK
Chua
T
. Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor . J Mol Med
2004 ; 82 : 539 –49 .
9.
Ye
L
Haider
HKh
Jiang
S
Tan
RS
Ge
R
Law
PK
. Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1 . Eur J Heart Fail
2007 ; 9 : 15 –22 .
10.
Skuk
D
Caron
N
Goulet
M
Roy
B
Espinosa
F
Tremblay
JP
. Dynamics of the early immune cellular reactions after myogenic cell transplantation . Cell Transplant
2002 ; 11 : 671 –81 .
11.
Haider
HKh
Jiang
SJ
Ye
L
Aziz
S
Law
PK
Sim
EK
. Effectiveness of transient immunosuppression using cyclosporine for xenotransplantation for cardiac repair . Transplantation Proceedings
2004 ; 36 : 232 –5 .
12.
Suzuki
K
Brand
NJ
Allen
S
Khan
MA
Farrell
AO
Murtuza
B
. Overexpression of connexin 43 in skeletal myoblasts: relevance to cell transplantation to the heart . J Thorac Cardiovasc Surg
2001 ; 122 : 759 –66 .
13.
Davis
ME
. Non-viral gene delivery systems [Review] . Curr Opin Biotechnol
2002 ; 13 : 128 –31 .
14.
Ye
L
Haider
HKh
Tan
RS
Toh
WC
Law
PK
Tan
WB
. Transplantation of nanoparticle based skeletal myoblasts over-expression vascular endothelial growth factor-165 for cardiac repair . Circulation
2006 ; 114 (Suppl II ): 398 –9 .
15.
Lee
RJ
Springer
ML
Blanco-Bose
WE
Shaw
R
Ursell
PC
Blau
HM
. VEGF gene delivery to myocardium: deleterious effects of unregulated expression . Circulation
2000 ; 102 : 898 –901 .
16.
Schwarz
ER
Speakman
MT
Patterson
M
Hale
SS
Isner
JM
Kedes
LH
. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat—angiogenesis and angioma formation . J Am Coll Cardiol
2000 ; 35 : 1323 –30 .
